Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06223568
What this trial is testing

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckOropharynxHuman Papillomavirus Viruses+2 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Looking for participantsNCT07287150
What this trial is testing

Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Hoffmann-La Roche 100
Large-scale testing (Phase 3)WithdrawnNCT00349518
What this trial is testing

Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic Leukemia
Bristol-Myers Squibb
Not applicableStudy completedNCT06064110
What this trial is testing

Pictou County PEP: A 6-Month, Home-Based, Personal Empowerment Program for Adults With a Chronic Medical Condition Living in Pictou County

Who this might be right for
Chronic Condition
Nova Scotia Health Authority 185
Testing effectiveness (Phase 2)Study completedNCT00917020
What this trial is testing

The Effect of Nasal Carbon Dioxide (CO2) Used As-Needed in the Symptomatic Treatment of Seasonal Allergic Rhinitis

Who this might be right for
Seasonal Allergic Rhinitis
Capnia, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT03845023
What this trial is testing

Trial of AD036 in Obstructive Sleep Apnea

Who this might be right for
Obstructive Sleep Apnea
Apnimed 140
Testing effectiveness (Phase 2)Looking for participantsNCT06823479
What this trial is testing

Towards Cure Via Only Ultra-short ICB in CSCC

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)Cutaneous Squamous Cell CancerCutaneous Squamous Cell Carcinoma of the Head and Neck+1 more
The Netherlands Cancer Institute 41
Testing effectiveness (Phase 2)Study completedNCT03486080
What this trial is testing

Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction

Who this might be right for
Acute Myocardial InfarctionAcute Myocardial IschemiaSTEMI - ST Elevation Myocardial Infarction
Recardio, Inc. 49
Testing effectiveness (Phase 2)Study completedNCT01499225
What this trial is testing

A Clinical Trial of YH14642 in Patients With Chronic Periodontal Disease

Who this might be right for
Chronic Periodontitis
Yuhan Corporation 162
Testing effectiveness (Phase 2)Study completedNCT00479817
What this trial is testing

Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Amgen 161
Not applicableUnknownNCT06570317
What this trial is testing

Nintedanib for the Prevention of Radiation Pneumonia in Unresectable NSCLC

Who this might be right for
NSCLCNintedanibRadiation Pneumonitis
Second Hospital of Shanxi Medical University 40
Testing effectiveness (Phase 2)Study completedNCT05116540
What this trial is testing

Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hope Biosciences Research Foundation 24
Testing effectiveness (Phase 2)Ended earlyNCT03311750
What this trial is testing

Anti-EGFR Therapy Rechallenge in Combination With Chemotherapy in Patients With Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Hellenic Cooperative Oncology Group 23
Testing effectiveness (Phase 2)Ended earlyNCT01870791
What this trial is testing

Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer

Who this might be right for
Esophageal NeoplasmGastric Neoplasm
University Hospitals, Leicester 21
Testing effectiveness (Phase 2)Study completedNCT01511250
What this trial is testing

Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years

Who this might be right for
Healthy
Takeda 360
Testing effectiveness (Phase 2)WithdrawnNCT01913691
What this trial is testing

Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma

Who this might be right for
Merkel Cell Carcinoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00656890
What this trial is testing

MDX-1100 in Subjects With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Bristol-Myers Squibb 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07563010
What this trial is testing

Menin-Inhibitor Targeted Maintenance in AML

Who this might be right for
Relapsed Adult AMLStem Cell Transplant ComplicationsAcute Myeloid Leukemia+1 more
Center for International Blood and Marrow Transplant Research 146
Testing effectiveness (Phase 2)Study completedNCT00085813
What this trial is testing

Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
GlaxoSmithKline 70
Large-scale testing (Phase 3)Study completedNCT01197560
What this trial is testing

Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
Celgene 111
Next Page